Premium
P2‐027: PHARMACOKINETICS AND SAFETY PROFILE OF SINGLE‐DOSE ADMINISTRATION OF AN ESTROGEN RECEPTOR β‐SELECTIVE PHYTOESTROGENIC (PHYTOSERM) FORMULATION IN WOMEN WITH COGNITIVE DEFICITS AND MENOPAUSAL SYMPTOMS
Author(s) -
Hernandez Gerson D.,
Zhao Liqin,
Mack Wendy J.,
Schneider Lon S.,
Brinton Roberta Diaz
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.1249
Subject(s) - phytoestrogens , medicine , daidzein , selective estrogen receptor modulator , menopause , estrogen , equol , pharmacokinetics , adverse effect , endocrinology , estrogen receptor , hormone replacement therapy (female to male) , pharmacology , tolerability , genistein , breast cancer , cancer , testosterone (patch)